Alto Neuroscience Inc
(ANRO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||
| Net Income | -7,284 | -27,710 | -9,187 |
| Depreciation Amortization | 86 | 342 | 145 |
| Accounts payable and accrued liabilities | -649 | N/A | N/A |
| Other Working Capital | -976 | 4,579 | -572 |
| Other Operating Activity | 1,299 | 2,395 | 352 |
| Operating Cash Flow | $-7,524 | $-20,394 | $-9,262 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -21 | -732 | -680 |
| Investing Cash Flow | $-21 | $-732 | $-680 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 25,000 | 43,789 | 31,688 |
| Financing Cash Flow | $25,000 | $43,789 | $31,688 |
| Exchange Rate Effect | -19 | -24 | -50 |
| Beginning Cash Position | 48,344 | 25,705 | 4,009 |
| End Cash Position | 65,780 | 48,344 | 25,705 |
| Net Cash Flow | $17,436 | $22,639 | $21,696 |
| Free Cash Flow | |||
| Operating Cash Flow | -7,524 | -20,394 | -9,262 |
| Capital Expenditure | -21 | N/A | N/A |
| Free Cash Flow | -7,545 | -20,394 | -9,262 |